Stay updated with breaking news from Roberto Galea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Amulet and Watchman FLX devices for left atrial appendage closure produced equivalent results, with about half of patients having residual patency of the appendage at 13 months, a study shows.
The SWISS-APERO analysis shows that roughly half of patients overall have patent appendages detected by CT.
The two devices continue to lead to similar clinical outcomes
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
This randomized clinical trial examines the effect of early administration of the PCSK9 inhibitor alirocumab on coronary atherosclerosis using serial multimodal